BioCentury
ARTICLE | Company News

China approves Simcere's iguratimod for RA

August 25, 2011 11:37 PM UTC

Simcere Pharmaceutical Group (NYSE:SCR) said China's State Food and Drug Administration approved Iremod iguratimod to treat rheumatoid arthritis. Iremod selectively inhibits cyclooxygenase-2 (COX-2) a...